Liver Diseases  >>  GI-5005  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
GI-5005 / GlobeImmune
NCT00124215: Safety and Efficacy of the Therapeutic Vaccine GI-5005 Versus Placebo for the Treatment of Chronic Hepatitis C Infection

Completed
1
48
US
GI-5005
GlobeImmune
Hepatitis C
06/07
02/10

Download Options